Current Value
$30.541 Year Return
Current Value
$30.541 Year Return
Double maintains 8 strategies that include MRNA - Moderna, Inc.
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| TGI | -0.01% | $2.00B | +63.68% | 0.00% |
| MAX | -0.05% | $581.31M | -16.93% | 0.00% |
| BTI | 0.06% | $103.67B | +50.78% | 6.33% |
| OHI | -0.08% | $10.56B | +7.99% | 7.35% |
| UNH | 0.10% | $279.00B | -37.22% | 2.74% |
| KMB | -0.10% | $43.92B | -3.75% | 3.75% |
| XGN | -0.11% | $152.37M | +285.08% | 0.00% |
| PGR | -0.12% | $151.13B | +22.60% | 1.89% |
| ADC | 0.13% | $7.93B | +16.41% | 4.21% |
| OGE | 0.15% | $8.90B | +24.24% | 3.80% |
| NEXA | 0.19% | $659.55M | -36.15% | 0.00% |
| RLI | 0.21% | $6.46B | +4.43% | 1.26% |
| AWR | 0.21% | $2.98B | +8.16% | 2.41% |
| ELS | -0.21% | $11.78B | -3.08% | 3.23% |
| T | 0.25% | $203.71B | +51.55% | 3.92% |
| NEUE | 0.26% | $61.24M | +29.92% | 0.00% |
| TU | 0.29% | $24.75B | +7.77% | 7.12% |
| UTZ | -0.30% | $1.14B | -19.23% | 1.82% |
| PSQH | 0.33% | $98.82M | -36.55% | 0.00% |
| NTGR | -0.33% | $837.31M | +97.35% | 0.00% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| BTAL | -39.18% | $296.22M | 1.43% |
| VIXY | -33.97% | $164.54M | 0.85% |
| TAIL | -32.35% | $99.63M | 0.59% |
| IVOL | -17.46% | $347.03M | 1.02% |
| XONE | -16.47% | $625.28M | 0.03% |
| STPZ | -13.82% | $450.47M | 0.2% |
| SCHO | -13.75% | $11.03B | 0.03% |
| SPTS | -13.68% | $5.80B | 0.03% |
| SHYM | -13.56% | $357.13M | 0.35% |
| UTWO | -12.41% | $379.52M | 0.15% |
| IBTG | -11.46% | $1.92B | 0.07% |
| FTSD | -11.22% | $231.81M | 0.25% |
| IBTH | -10.89% | $1.62B | 0.07% |
| VTIP | -10.71% | $15.33B | 0.03% |
| FXY | -10.63% | $816.38M | 0.4% |
| VGSH | -10.53% | $22.80B | 0.03% |
| BILS | -10.52% | $3.81B | 0.1356% |
| TDTT | -10.33% | $2.64B | 0.18% |
| STIP | -10.24% | $12.72B | 0.03% |
| IBTK | -9.85% | $448.89M | 0.07% |
Yahoo
The company was pleased to report the findings of a late-stage clinical trial of its advanced flu vaccine. Moderna (NASDAQ: MRNA), the next-generation healthcare company most famous for developing the Spikevax coronavirus vaccine, was an uncharacteristically popular stock. On Monday, Moderna published the results of a late-stage study of mRNA-1010, its seasonal flu vaccine.
Yahoo
In late June 2025, Moderna (NasdaqGS:MRNA) underwent significant index changes, adding to the Russell Midcap indices while exiting the Russell Top 200 indices. This reclassification might have signaled a shift in investor perception, aligning with the company's 18% share price increase over the last quarter. Despite the broader market experiencing a rally with indexes like the S&P 500 and Nasdaq reaching record highs, Moderna's earnings report, strategic alliances, and product-related updates...
Yahoo
Moderna rises as CDC expands RSV vaccine guidance to include high-risk adults aged 50-59, boosting mResvia's reach.
Yahoo
The RSV vaccine is now recommended for adults aged 50 to 59 who are at a high risk of severe infection.
Yahoo
Moderna stock popped Wednesday after the CDC recommended the company's RSV vaccine for at-risk adults in their 50s.
Yahoo
SLNs are a type of nanocarrier used in drug delivery and vaccine development. They are composed of stabilized lipids and can encapsulate active pharmaceutical ingredients (APIs). This formulation approach can enable the transport of active molecules directly to target cells, protect encapsulated molecules from degradation, and enhance the solubility and bioavailability of poorly soluble drugs. The most well-known SLN formulations include the Moderna and Pfizer COVID-19 vaccines. However, there i
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| GNOM | 59.37% | $44.57M | 0.5% |
| IBB | 54.35% | $5.26B | 0.45% |
| XBI | 53.60% | $4.82B | 0.35% |
| BBH | 51.41% | $330.62M | 0.35% |
| ARKG | 50.50% | $1.02B | 0.75% |
| FBT | 47.52% | $1.01B | 0.54% |
| QQQJ | 46.20% | $621.52M | 0.15% |
| ROBT | 45.63% | $498.76M | 0.65% |
| XSD | 45.54% | $1.29B | 0.35% |
| ROBO | 45.30% | $1.05B | 0.95% |
| PBE | 45.20% | $223.19M | 0.58% |
| DRIV | 45.19% | $303.50M | 0.68% |
| SPHB | 45.14% | $393.85M | 0.25% |
| XT | 45.07% | $3.40B | 0.46% |
| SNSR | 44.98% | $225.36M | 0.68% |
| MOAT | 44.35% | $12.66B | 0.47% |
| PBD | 43.50% | $72.92M | 0.75% |
| IWC | 43.46% | $818.14M | 0.6% |
| RSPT | 43.31% | $3.61B | 0.4% |
| IWO | 43.18% | $11.60B | 0.24% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| EXC | -20.32% | $43.33B | +23.58% | 3.62% |
| ED | -15.36% | $36.00B | +12.64% | 3.34% |
| KR | -14.11% | $46.43B | +38.38% | 1.85% |
| DUK | -13.58% | $90.99B | +17.25% | 3.56% |
| SO | -12.09% | $100.18B | +17.28% | 3.18% |
| CBOE | -11.75% | $24.23B | +35.36% | 1.09% |
| K | -11.63% | $27.76B | +41.17% | 2.85% |
| TMUS | -11.47% | $269.58B | +33.04% | 1.38% |
| CME | -10.53% | $99.39B | +40.68% | 3.86% |
| MSIF | -10.28% | $769.47M | +36.17% | 7.61% |
| MCK | -9.94% | $88.11B | +20.93% | 0.40% |
| MO | -9.89% | $99.67B | +28.77% | 6.90% |
| COKE | -8.95% | $9.06B | +6.17% | 6.89% |
| ALHC | -7.86% | $2.69B | +71.20% | 0.00% |
| KO | -7.82% | $305.22B | +11.97% | 2.81% |
| COR | -7.82% | $56.44B | +30.86% | 0.74% |
| AEP | -7.55% | $55.16B | +17.93% | 3.54% |
| RYAN | -7.25% | $8.33B | +14.50% | 0.70% |
| LMT | -7.11% | $108.37B | -0.75% | 2.81% |
| WEC | -7.06% | $33.11B | +33.56% | 3.32% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| ISTB | -0.01% | $4.44B | 0.06% |
| UBND | 0.02% | $1.02B | 0.4% |
| BIV | -0.06% | $23.39B | 0.03% |
| VMBS | 0.09% | $14.48B | 0.03% |
| SMMU | -0.12% | $892.02M | 0.35% |
| CGMU | 0.16% | $3.36B | 0.27% |
| TLT | -0.21% | $48.41B | 0.15% |
| EDV | 0.22% | $3.48B | 0.05% |
| BBAG | -0.24% | $1.29B | 0.03% |
| HTRB | -0.28% | $2.02B | 0.29% |
| TIP | -0.31% | $13.96B | 0.18% |
| EUSB | 0.34% | $735.36M | 0.12% |
| HYMB | -0.44% | $2.63B | 0.35% |
| VCRB | -0.47% | $3.13B | 0.1% |
| GOVZ | -0.51% | $272.00M | 0.1% |
| GBIL | 0.57% | $6.37B | 0.12% |
| IBMO | 0.60% | $526.24M | 0.18% |
| BOND | -0.65% | $5.67B | 0.7% |
| JUCY | 0.65% | $269.70M | 0.6% |
| IBMN | 0.69% | $447.08M | 0.18% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| ARCT | 51.42% | $369.38M | -37.89% | 0.00% |
| BNTX | 50.09% | $26.02B | +35.56% | 0.00% |
| LSCC | 48.10% | $7.19B | -16.13% | 0.00% |
| CRSP | 47.76% | $4.46B | -4.14% | 0.00% |
| COHU | 47.42% | $953.77M | -38.54% | 0.00% |
| IPGP | 46.79% | $3.12B | -13.24% | 0.00% |
| NVAX | 45.97% | $1.09B | -46.14% | 0.00% |
| TEL | 45.20% | $51.42B | +16.55% | 1.53% |
| DIOD | 44.56% | $2.63B | -21.82% | 0.00% |
| RGNX | 44.55% | $434.35M | -20.33% | 0.00% |
| KLIC | 44.47% | $1.94B | -25.30% | 2.20% |
| AEIS | 44.37% | $5.18B | +28.61% | 0.29% |
| NXPI | 43.72% | $58.40B | -15.11% | 1.76% |
| SLAB | 43.71% | $4.97B | +37.05% | 0.00% |
| RXRX | 43.45% | $2.12B | -29.12% | 0.00% |
| A | 43.19% | $34.28B | -4.34% | 1.00% |
| PFE | 43.05% | $143.95B | -8.59% | 6.72% |
| QCOM | 42.88% | $178.23B | -20.36% | 2.11% |
| CRBU | 42.84% | $127.42M | -14.38% | 0.00% |
| ON | 42.80% | $23.38B | -23.02% | 0.00% |
